[

antibody

]
Recent analyses indicate that pregnant women and newborns may face elevated risks of developing more severe cases of Covid-19 following SARS-CoV-2 infection.(Pixabay)

Research reveals compromised transfer of SARS-CoV-2-specific antibodies through placenta

By Asian News International | Posted by Shivani Kale | Washington
UPDATED ON DEC 24, 2020 05:20 PM IST
Recent analyses indicate that pregnant women and newborns may face elevated risks of developing more severe cases of Covid-19 following SARS-CoV-2 infection.
Close
Artist Mundano works on a graffiti called Invisible Heroines, a tribute to women braving pandemic in Sao Paulo, Brazil.
Artist Mundano works on a graffiti called Invisible Heroines, a tribute to women braving pandemic in Sao Paulo, Brazil.

Baby born with antibodies in Singapore

By Agencies | Singapore
PUBLISHED ON NOV 30, 2020 01:36 AM IST
The baby was born this month without Covid-19 but with the virus antibodies, the Straits Times newspaper reported on Sunday, citing the mother.
Close
The authors suggest that their findings may inform strategies to develop universal vaccines against emerging and future coronaviruses.(ANI)
The authors suggest that their findings may inform strategies to develop universal vaccines against emerging and future coronaviruses.(ANI)

Antibodies from patients infected with SARS-CoV in 2003 cross-neutralised SARS-CoV-2 in vitro: Study

By Asian News International| Posted by Susmita Pakrasi | Washington
UPDATED ON OCT 10, 2020 02:15 PM IST
The authors also report that, surprisingly, mice and rabbits immunised with a receptor-binding domain (RBD) from a strain of SARS-CoV that infects the Himalayan palm civet elicited stronger antibody responses against SARS-CoV-2 than animals immunised with an RBD from a human SARS-CoV strain.
Close
The study, published in the journal Science, points to the IgG class of antibodies as the longest-lasting antibodies detectable in the patients during this time frame, and may serve as promising targets to detect and evaluate immune responses against the SARS-CoV-2 virus.(HT File Photo)
The study, published in the journal Science, points to the IgG class of antibodies as the longest-lasting antibodies detectable in the patients during this time frame, and may serve as promising targets to detect and evaluate immune responses against the SARS-CoV-2 virus.(HT File Photo)

Scientists detect long-lived antibodies in blood, saliva samples from Covid-19 patients

By Press Trust of India| Posted by Susmita Pakrasi | New York
UPDATED ON OCT 09, 2020 03:27 PM IST
The scientists focused only on antibodies specific to the receptor binding domain of the SARS-CoV-2 spike protein which it uses to enter host cells.
Close
(Twitter/WebMD)
(Twitter/WebMD)

Study reveals antibodies against coronavirus stay in body for 60-80 days

By Press Trust of India | Posted by Zarafshan Shiraz | New Delhi
UPDATED ON SEP 05, 2020 10:11 AM IST
Indian researchers understand coronavirus infection recovery and re-infection pattern better after study reveals that anti SARS-CoV-2 antibodies could remain for more than 60 days in the body
Close
A medical worker collects a blood sample for the second serological survey sampling in early August in New Delhi.(Amal KS/HT Photo)
A medical worker collects a blood sample for the second serological survey sampling in early August in New Delhi.(Amal KS/HT Photo)

29% of Delhi has antibodies for Covid-19: Second sero-survey

By Sweta Goswami and Abhishek Dey | Hindustan Times, New Delhi
UPDATED ON AUG 20, 2020 03:42 PM IST
The findings of the second survey show that the prevalence of antibodies among the people has increased by over 6 percentage points when compared to the first survey held between June 27 and July 10
Close
A health worker gears up for collecting swab samples to test for Covid-19, Pune, Maharashtra, June 19, 2020(Pratham Gokhale/HT Photo)
A health worker gears up for collecting swab samples to test for Covid-19, Pune, Maharashtra, June 19, 2020(Pratham Gokhale/HT Photo)

The twin tales of vanishing antibodies, robust T-cells | Opinion

By Narinder Kumar Mehra
UPDATED ON JUL 23, 2020 06:27 PM IST
Studies have explained immunity to Covid-19, but there’s no clarity on the grades of immune responses of people
Close
The DSO said that its scientists have screened “hundreds of thousands” of B cells - the cells that produce antibodies to target pathogens - from the blood samples of recovered Covid-19 patients since March this year.(via REUTERS)
The DSO said that its scientists have screened “hundreds of thousands” of B cells - the cells that produce antibodies to target pathogens - from the blood samples of recovered Covid-19 patients since March this year.(via REUTERS)

Singapore scientists discover 5 antibodies that can combat Covid-19

By Press Trust of India | Singapore
PUBLISHED ON JUN 17, 2020 02:23 PM IST
Human trials for the lead antibody, AOD01, will commence in the coming months, pending approval from the Health Sciences Authority, said the Defense Science Organisation (DSO) National Laboratories.
Close
Preliminary tests of the two antibodies, named B38 and H4, in a mouse model resulted in a reduction of virus titers, the researchers said.(REUTERS)
Preliminary tests of the two antibodies, named B38 and H4, in a mouse model resulted in a reduction of virus titers, the researchers said.(REUTERS)

Twin antibodies that may help fight Covid-19 identified

By Press Trust of India | Beijing
PUBLISHED ON MAY 14, 2020 02:02 PM IST
The antibodies identified by the researchers, including those from Chinese Academy of Sciences, bind to the glycoprotein spike of the SARS-CoV-2 virus, blocking the spike’s ability to bind to the human ACE2 receptor and mediate viral entry into host cells.
Close
Over 2,231,438 people have been infected with Covid-19 worldwide.(Reuters)
Over 2,231,438 people have been infected with Covid-19 worldwide.(Reuters)

WHO unsure antibodies protect against Covid-19, little sign of herd immunity

By Reuters | Geneva
PUBLISHED ON APR 18, 2020 09:38 AM IST
Mike Ryan, the WHO’s top emergencies expert, also said that even if antibodies were effective there was little sign that large numbers of people had developed them and were beginning to offer so-called “herd immunity” to the broader population.
Close
SHARE
Story Saved